RUBIUS THERAPEUTICS INC's ticker is RUBY and the CUSIP is 78116T103. A total of 108 filers reported holding RUBIUS THERAPEUTICS INC in Q3 2021. The put-call ratio across all filers is 0.43 and the average weighting 0.2%.
Links
Filings
- All filings
- Annual reports (20-F)
- Quarterly reports (6-K)
- Insider transactions
- Shareholder votes
- Significant ownership
- Events
EDGAR links
External links
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q4 2022 | $13,080 | +161.6% | 72,662 | +506.2% | 0.00% | – |
| Q3 2022 | $5,000 | +66.7% | 11,986 | +2196.2% | 0.00% | – |
| Q1 2022 | $3,000 | -99.7% | 522 | -99.5% | 0.00% | – |
| Q4 2021 | $1,028,000 | -29.4% | 106,204 | +30.4% | 0.00% | – |
| Q3 2021 | $1,457,000 | +70.8% | 81,470 | +133.2% | 0.00% | – |
| Q2 2021 | $853,000 | -7.8% | 34,933 | +0.1% | 0.00% | – |
| Q1 2021 | $925,000 | +4104.5% | 34,911 | +1112.2% | 0.00% | – |
| Q4 2020 | $22,000 | +340.0% | 2,880 | +188.0% | 0.00% | – |
| Q3 2020 | $5,000 | -64.3% | 1,000 | -56.3% | 0.00% | – |
| Q2 2020 | $14,000 | -75.0% | 2,288 | -82.0% | 0.00% | – |
| Q1 2020 | $56,000 | -84.2% | 12,714 | -65.8% | 0.00% | – |
| Q4 2019 | $354,000 | +353.8% | 37,222 | +273.7% | 0.00% | – |
| Q3 2019 | $78,000 | – | 9,961 | +43208.7% | 0.00% | – |
| Q1 2019 | $0 | -100.0% | 23 | -99.2% | 0.00% | – |
| Q3 2018 | $69,000 | – | 2,868 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| CONCOURSE FINANCIAL GROUP SECURITIES, INC. | 0 | $0 | 0.00% |